Atlas Trials

Comparisons of Inhaled LAMA or LAMA+LABA or ICS+LABA for COPD With Bronchiectasis

Clinical trial NCT02546297 · UNKNOWN

Trial details

NCT number
NCT02546297
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
COPDBronchiectasis
Start date
2017-09-15
Primary completion
2020-09-15
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.